Letters to the Editor
Family History and Genetic Testing for Cancer Risk
FREE PREVIEW Log in or buy this issue to read the full article. AAFP members and paid subscribers get free access to all articles. Subscribe now.
FREE PREVIEW Subscribe or buy this issue. AAFP members and paid subscribers get free access to all articles.
Am Fam Physician. 2010 Apr 15;81(8):934-938.
Original Article: Assessing Breast Cancer Risk in Women
Issue Date: December 15, 2008
Available at: http://www.aafp.org/afp/2008/1215/p1361.html
to the editor: I am glad that American Family Physician featured the important topic of assessing cancer risk, and breast cancer risk in particular. However, there are inaccuracies that need to be corrected in the section “Genetic Mutations and Family History.”
The article states, “The U.S. Preventive Services Task Force (USPSTF) has recommended that physicians offer genetic testing to several groups of women.” 1 Readers are referred to Table 2, which details USPSTF recommendations for testing for BRCA mutations based on family history criteria. However, the specific recommendation of the USPSTF is that women who have not had breast or ovarian cancer be referred for genetic counseling (and consideration of testing) if their family history meets certain criteria.2
There are two serious problems with stating that people who meet these family history criteria “should be tested” for BRCA mutations that confer susceptibility to cancer. First, a substantial proportion of people with such family histories will have a low pretest probability of carrying a deleterious BRCA mutation.3,4 Testing these persons might be unnecessary, but advising them about familial risk, cancer screening, and prevention might still be important. Furthermore, current testing does not identify all deleterious BRCA gene alterations, and the clinical significance of some gene variants is uncertain. Second, for most people whose family history suggests increased risk for hereditary breast and ovarian cancer, proceeding to genetic testing without first testing a family member who has had breast or ovarian cancer will be uninformative.5,6 For these reasons, the USPSTF recommends referring some women for genetic counseling to determine if BRCA gene sequencing is indicated. Genetic testing for all persons who meet family history criteria could be a colossal waste of resources. In contrast, widespread testing has been advocated for women in population subgroups, such as Ashkenazi Jews who have a higher risk for three particular BRCA mutations7; however, pretest and post-test counseling would still be essential.
The footnote to Table 2 states, “Second-degree relatives include grandparents, aunts, uncles, and cousins.” Except in families with consanguinity, first cousins are actually third-degree relatives, with one eighth of their genetic material in common. Second-degree relatives have one fourth of their genetic material in common. Cousins are not included in the USPSTF recommendations nor in most other rule-based criteria for increased risk of inherited breast cancer, though they may sometimes be important in an analysis of a detailed pedigree. I heartily endorse the goal of recording the family cancer history of maternal and paternal relatives, including their ages at diagnosis.
1. Nelson HD, Huffman LH, Fu R, Harris EL, U.S. Preventive Services Task Force. Genetic risk assessment and BRCA mutation testing for breast and ovarian cancer susceptibility: systematic evidence review for the U.S. Preventive Services Task Force [published correction appears in Ann Intern Med. 2005;143(7):547] Ann Intern Med. 2005;143(5):362–379.
2. U. S. Preventive Services Task Force. Genetic risk assessment and BRCA mutation testing for breast and ovarian cancer susceptibility: recommendation statement [published correction appears in Ann Intern Med. 2005;143(7):547] Ann Intern Med. 2005;143(5):355–361.
3. Palomaki GE, McClain MR, Steinort K, Sifri R, LoPresti L, Haddow JE. Screen-positive rates and agreement among six family history screening protocols for breast/ovarian cancer in a population-based cohort of 21- to 55-year-old women Genet Med. 2006;8(3):161–168.
4. Parmigiani G, Chen S, Iversen ES Jr, et al. Validity of models for predicting BRCA1 and BRCA2 mutations Ann Intern Med. 2007;147(7):441–450.
5. Centers for Disease Control and Prevention. National Office of Public Health Genomics. ACCE Model System for Collecting, Analyzing and Disseminating Information on Genetic Tests. http://www.cdc.gov/genomics/gtesting/ACCE/FBR/index.htm. Accessed December 22, 2008.
6. Trepanier A, Ahrens M, McKinnon W, et al. Genetic cancer risk assessment and counseling: recommendations of the national society of genetic counselors J Genet Couns. 2004;13(2):83–114.
7. Rubinstein WS, Jiang H, Dellefave L, Rademaker AW. Cost-effectiveness of population-based BRCA1/2 testing and ovarian cancer prevention for Ashkenazi Jews: a call for dialogue Genet Med. 2009;11(9):629–639.
in reply: We thank Dr. Acheson for her careful reading of our article. We agree completely with her statement about the USPSTF recommendations and regret that the statement was inadvertently shortened to its printed form during the editing process. We agree that, in general, cousins are not classified as second-degree relatives. However, our personal clinical experience and conversations with colleagues suggest that many patients do not know the health history of older relatives such as aunts and uncles, because that generation may have been less likely to disclose details of their personal health to younger relatives. In these cases, knowing the health history of cousins might provide clues or suggestions that are worth considering as part of the general decision about genetic counseling.
Send letters to Kenneth W. Lin, MD, MPH, Associate Deputy Editor for AFP Online, e-mail: email@example.com, or 11400 Tomahawk Creek Pkwy., Leawood, KS 66211-2680.
Please include your complete address, e-mail address, and telephone number. Letters should be fewer than 400 words and limited to six references, one table or figure, and three authors.
Letters submitted for publication in AFP must not be submitted to any other publication. Possible conflicts of interest must be disclosed at time of submission. Submission of a letter will be construed as granting the American Academy of Family Physicians permission to publish the letter in any of its publications in any form. The editors may edit letters to meet style and space requirements.
Copyright © 2010 by the American Academy of Family Physicians.
This content is owned by the AAFP. A person viewing it online may make one printout of the material and may use that printout only for his or her personal, non-commercial reference. This material may not otherwise be downloaded, copied, printed, stored, transmitted or reproduced in any medium, whether now known or later invented, except as authorized in writing by the AAFP. Contact firstname.lastname@example.org for copyright questions and/or permission requests.
Want to use this article elsewhere? Get Permissions